跳至主要内容
临床试验/JPRN-jRCT1040220010
JPRN-jRCT1040220010招募中未知

An observational study on treatment patterns and outcomes among patients with metastatic or recurrent esophageal cancer: Real world data and empirical analysis in Japan - POME

Kei Muro0 个研究点目标入组 1,000 人开始时间: 2022年4月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1.Patients diagnosed with metastatic or recurrent esophageal squamous or adenosquamous cancer from January 1, 2013 to December 31, 2018
  • 2. Age: 20 years or older
  • 3. Patients in the above categories (1) to (4) of patients eligible for chemotherapy for esophageal cancer from January 2013 to the end of December 2018 who have received chemotherapy for metastasis or recurrence
  • 4. Patients from whom appropriate consent is obtained (see General Informed Consent)
  • All inclusion and exclusion criteria will be reviewed by the investigator or qualified designee to ensure that the subject qualifies for the study.

排除标准

  • Patients who were registered in a clinical study at the time of the first chemotherapy treatment for metastatic or recurrent esophageal cancer

研究者

发起方
Kei Muro

相似试验